ATE468538T1 - Testverfahren und kit zur vorhersage des implantationserfolgs bei unterstützter befruchtung - Google Patents

Testverfahren und kit zur vorhersage des implantationserfolgs bei unterstützter befruchtung

Info

Publication number
ATE468538T1
ATE468538T1 AT07787688T AT07787688T ATE468538T1 AT E468538 T1 ATE468538 T1 AT E468538T1 AT 07787688 T AT07787688 T AT 07787688T AT 07787688 T AT07787688 T AT 07787688T AT E468538 T1 ATE468538 T1 AT E468538T1
Authority
AT
Austria
Prior art keywords
kit
test procedure
assisted fertilization
csf
implantation success
Prior art date
Application number
AT07787688T
Other languages
English (en)
Inventor
Nathalie Ledee
St-Germain En Laye Poissy
Marie-Pierre Piccinni
Raoul Lombroso
Gaillard
Original Assignee
Mithra Pharmaceuticals Nv Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mithra Pharmaceuticals Nv Sa filed Critical Mithra Pharmaceuticals Nv Sa
Application granted granted Critical
Publication of ATE468538T1 publication Critical patent/ATE468538T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07787688T 2006-07-21 2007-07-18 Testverfahren und kit zur vorhersage des implantationserfolgs bei unterstützter befruchtung ATE468538T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83209406P 2006-07-21 2006-07-21
PCT/EP2007/057430 WO2008009705A1 (en) 2006-07-21 2007-07-18 Assay and kit for predicting implantation success in assisted fertilisation

Publications (1)

Publication Number Publication Date
ATE468538T1 true ATE468538T1 (de) 2010-06-15

Family

ID=38529962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07787688T ATE468538T1 (de) 2006-07-21 2007-07-18 Testverfahren und kit zur vorhersage des implantationserfolgs bei unterstützter befruchtung

Country Status (21)

Country Link
US (1) US8211650B2 (de)
EP (5) EP2857840B8 (de)
JP (1) JP5052609B2 (de)
KR (2) KR101482568B1 (de)
CN (2) CN106199004B (de)
AT (1) ATE468538T1 (de)
AU (1) AU2007275112B2 (de)
BR (1) BRPI0714494B1 (de)
CA (1) CA2658665C (de)
DE (1) DE602007006672D1 (de)
DK (2) DK2214021T3 (de)
EA (1) EA016348B1 (de)
ES (4) ES2345571T3 (de)
HK (2) HK1128760A1 (de)
HR (2) HRP20100382T8 (de)
MX (1) MX2009000569A (de)
MY (1) MY150687A (de)
NZ (1) NZ574135A (de)
PL (2) PL2214021T3 (de)
PT (2) PT2049906E (de)
WO (1) WO2008009705A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338373B2 (en) 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
EP2140875A1 (de) 2003-10-24 2010-01-06 Nora, LLC Zusammensetzungen und Verfahren für eine gesunde Schwangerschaft
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US9176145B2 (en) 2006-07-21 2015-11-03 Femalon S.P.R.L. Kit for predicting implantation success in assisted fertilization
GB0806281D0 (en) * 2008-04-07 2008-05-14 Univ Leeds Markers of Oocyte viability
JP5902478B2 (ja) * 2008-05-01 2016-04-13 ザイモジェネティクス, インコーポレイテッド 血清中のBLyS/APRILヘテロ三量体レベルおよび診断方法における使用
WO2010126528A1 (en) * 2009-05-01 2010-11-04 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
WO2010151221A1 (en) * 2009-06-25 2010-12-29 Phase Holographic Imaging Phi Ab Analysis of ova or embryos with digital holographic imaging
WO2011000805A1 (en) 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
US9753042B2 (en) * 2013-04-23 2017-09-05 Rosalind Franklin University Of Medicine And Science Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
EP3126836A4 (de) * 2014-04-02 2017-11-08 Prince Henry's Insitute of Medical Research Trading as The Hudson Institute of Medical Research Prognostischer test auf erfolg von technologien zur unterstützten fortpflanzung
CN104450904A (zh) * 2014-12-02 2015-03-25 柳州市妇幼保健院 利用颗粒细胞端粒长度来判断胚胎发育潜能的方法
AU2016330398B2 (en) * 2015-09-30 2022-11-10 Hudson Institute of Medical Research A method of treatment and prognosis
CN110361534B (zh) * 2018-03-26 2023-11-03 山大生殖研发中心有限公司 评估胚胎和预测体外受精成功率的化学标记物和其应用
RU2746644C1 (ru) * 2021-01-21 2021-04-19 Мекан Рахимбердыевич Оразов Способ оценки имплантационной состоятельности эндометрия при повторных неудачах имплантации, ассоциированных с хроническим эндометритом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
ATE167301T1 (de) 1988-03-24 1998-06-15 Terrapin Tech Inc Gruppe von getrennten peptiden
JP3058673B2 (ja) * 1989-11-10 2000-07-04 株式会社明電舎 サイトカインの測定方法及びその測定用キット
GB9603326D0 (en) 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
JP5271481B2 (ja) * 1999-09-08 2013-08-21 中外製薬株式会社 タンパク質溶液製剤およびその安定化方法
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
JP4444652B2 (ja) 2001-07-11 2010-03-31 マキシゲン・ホールディングズ・リミテッド G−csf結合体

Also Published As

Publication number Publication date
PL2049906T3 (pl) 2010-10-29
US20090312596A1 (en) 2009-12-17
EP2857840A1 (de) 2015-04-08
EP2857840B1 (de) 2017-06-14
ES2531853T3 (es) 2015-03-20
HRP20100382T1 (hr) 2010-08-31
NZ574135A (en) 2011-11-25
AU2007275112A1 (en) 2008-01-24
EP2214021A1 (de) 2010-08-04
PT2214021E (pt) 2015-03-11
DK2214021T3 (en) 2015-02-16
ES2634527T3 (es) 2017-09-28
EP3267198A1 (de) 2018-01-10
DE602007006672D1 (de) 2010-07-01
US8211650B2 (en) 2012-07-03
BRPI0714494B1 (pt) 2018-05-08
CN101495871A (zh) 2009-07-29
EP2049906B1 (de) 2010-05-19
KR20140040289A (ko) 2014-04-02
ES2345571T3 (es) 2010-09-27
EA016348B1 (ru) 2012-04-30
EP2049906A1 (de) 2009-04-22
JP2009544934A (ja) 2009-12-17
EP3627156A1 (de) 2020-03-25
EA200900210A1 (ru) 2009-06-30
EP2214021B1 (de) 2015-01-07
WO2008009705A1 (en) 2008-01-24
HK1128760A1 (en) 2009-11-06
CN106199004B (zh) 2019-04-09
ES2754707T3 (es) 2020-04-20
HK1208529A1 (en) 2016-03-04
PT2049906E (pt) 2010-08-02
BRPI0714494A2 (pt) 2013-05-14
HRP20150251T1 (en) 2015-06-05
DK2049906T3 (da) 2010-07-05
CA2658665A1 (en) 2008-01-24
MY150687A (en) 2014-02-28
MX2009000569A (es) 2009-06-19
CA2658665C (en) 2017-09-26
AU2007275112B2 (en) 2012-07-12
EP3267198B1 (de) 2019-09-04
HRP20100382T8 (en) 2010-10-31
CN106199004A (zh) 2016-12-07
KR20090056986A (ko) 2009-06-03
EP2857840B8 (de) 2017-08-02
PL2214021T3 (pl) 2015-06-30
KR101482568B1 (ko) 2015-01-14
JP5052609B2 (ja) 2012-10-17

Similar Documents

Publication Publication Date Title
ATE468538T1 (de) Testverfahren und kit zur vorhersage des implantationserfolgs bei unterstützter befruchtung
BR112012028789A2 (pt) aparelho de teste de fluido e métodos de uso
MY180473A (en) Imaging and evaluating embryos, oocytes, and stem cells
PA8672101A1 (es) Anticuerpos anti-il-6, composiciones, métodos y usos
DE602007012766D1 (de) Verfahren zur quantitativen cDNA-Analyse in Einzelzellen
EP2657697A3 (de) Verfahren zur Bestimmung des Risikos von Komplikationen bei einem Fetus
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
MX2009003583A (es) Composiciones y ensayos multiples para medir mediadores biologicos de la salud fisiologica.
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2009125219A3 (en) Markers of oocyte viability
ATE434762T1 (de) Biologischer marker für entzündung
ATE463557T1 (de) Verfahren zur anreicherung fötaler zellen
SI2742359T1 (en) A new procedure and a set of in vitro fertilization in vitro predictors
NZ599813A (en) Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders
Tessaro et al. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test
ATE437220T1 (de) Verwendung von interleukin-17 für oozytenreifung
RU2006142106A (ru) Способ оценки фертильных свойств эякулята
FI20041453A0 (fi) Poistogeenisen eläimen malli
TH124016B (th) การถ่ายภาพและการประเมินเอมบริโอ (embryos),เซลล์เพศ (oocytes) และสเต็มเซลล์ (stem cells)
RU2012122473A (ru) Способ оценки днк-повреждений в тканях эмбрионов и плаценты животных
DK1996934T3 (da) Fremgangsmåde til at evaluere nyrefunktion i et kattedyr ved at måle ghrelinhomonniveauerne
RU2009104192A (ru) Способ идентификации фенотипически невыраженных форм сельскохозяйственной птицы
ITFI20040243A1 (it) Metodo diagnostico per la previsione di rigetto di organo trapiantato
TH8345A3 (th) กรรมวิธีการตรวจความสมบูรณ์ของอสุจิโคด้วยการวัดระดับอาร์เอ็นเอของยีน โปรตามีน
PL415440A1 (pl) Sposoby identyfikacji jagniąt syntetycznych linii BCP i SCP o przydatnym w hodowli składzie tkankowym tuszy

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2049906

Country of ref document: EP